Both conditions are evaluated, but the same principle applies: well-controlled means better underwriting outcomes. The threshold for what “well-controlled” means is specific and measurable.

How HIV and diabetes interact in underwriting

Life insurance underwriters evaluate each health condition in a portfolio, then assess the combined risk. Two co-morbidities do not simply add to each other mathematically; the interaction between conditions also matters.

HIV and diabetes together create a more complex underwriting profile than either alone because both conditions affect cardiovascular risk. HIV is associated with elevated cardiovascular risk through multiple mechanisms, including inflammation, immune activation, and effects of certain antiretroviral drugs. Diabetes is independently one of the leading risk factors for cardiovascular disease. When both are present and poorly controlled, the cardiovascular risk profile is substantially elevated. When both are well controlled, the risk profile is meaningfully better.

Underwriters look at whether the two conditions are compounding each other’s risks or whether they are each being managed to minimize their individual impacts. The goal in presenting your application is to demonstrate that both conditions are under effective control.

What type of diabetes you have matters

Carriers distinguish between type 1 and type 2 diabetes in their underwriting models:

Type 2 diabetes, which is far more common and is more directly linked to the metabolic effects of antiretroviral therapy, is more frequently encountered in the HIV-positive community and has more established underwriting pathways at HIV-friendly carriers. Type 1 diabetes combined with HIV presents a more challenging picture, though it is not automatically uninsurable.

The metrics carriers evaluate for diabetes

Beyond the type of diabetes, underwriters look at specific metrics that indicate how well it is controlled and whether complications have developed:

A person with type 2 diabetes with an HbA1c below 7.5%, no complications, managed with oral medication, represents a very different risk profile from someone with poorly controlled type 1 with retinopathy and recent DKA hospitalizations. Both are “diabetic,” but underwriters do not treat these profiles the same way.

HIV metrics remain the primary evaluation

Even with diabetes present, HIV metrics remain the primary framework for underwriting an HIV-positive applicant. The HIV evaluation gate must be passed first:

• Undetectable viral load is still required. No traditional carrier will overlook a detectable viral load because of otherwise well-controlled diabetes. The viral load threshold is non-negotiable at most carriers.
• CD4 count must be above carrier thresholds. The same CD4 requirements apply regardless of diabetes status.
• ART history and consistency are still evaluated. Treatment adherence standards apply to the HIV component.

Diabetes is then evaluated as a secondary condition, within the context of an already HIV-approved risk profile. Think of it as two layers of underwriting: the HIV layer is evaluated first, and if that clears the gate, the diabetes layer is then evaluated within the carrier’s framework for diabetic applicants.

Coverage options with both conditions

HIV-positive applicants with well-controlled diabetes may qualify for:

Traditional term or whole life at specialty carriers: A limited subset of carriers with HIV-specific underwriting who also have favorable diabetic underwriting may approve applicants with both conditions. Face amounts may be more limited than for HIV-only applicants. The premium rating will reflect both conditions, likely at a higher table than HIV alone would produce.

Guaranteed-issue whole life: These smaller policies ask no health questions, so a second condition does not affect acceptance. A $25,000 to $50,000 final expense policy may be achievable when a larger traditional policy is not.

Guaranteed issue: Available regardless of both conditions. Covers all causes of death after the graded benefit period. Face amounts limited to typically $5,000–$25,000. Guaranteed issue life insurance provides the coverage floor when other options are not available.

Work with a specialist broker who has experience placing applications for HIV-positive applicants with co-morbidities. The carrier selection step is especially important when multiple conditions are present.

Managing both conditions for better underwriting

The actions that improve your underwriting profile are the same actions that improve your health:

• Optimize diabetes control before applying. If your HbA1c is currently above 8%, work with your endocrinologist or primary care provider to improve it before submitting a life insurance application. Even a modest improvement from 8.5% to 7.8% can meaningfully affect underwriting.
• Get your HIV metrics current. Current viral load and CD4 documented within the past three to six months is essential.
• Address all diabetic complications actively. If you have early-stage retinopathy, nephropathy, or neuropathy, documentation that these are being monitored and managed is important. Unmonitored complications raise questions about overall disease management.
• Discuss ART-related metabolic effects with your HIV specialist. If your diabetes may be related to your ART regimen, your specialist can document this clinical context. Some modern ART regimens have significantly better metabolic profiles than older ones.
• Consider timing your application around your best labs. Apply when your most recent HbA1c and viral load are both favorable, not right after a difficult period.

Common questions about HIV, diabetes, and life insurance

Written and reviewed by Phillip Chin

Licensed Insurance Broker · NPN #8895251. Phillip is an independent broker who specializes in life insurance for people living with HIV, comparing the carriers that actually approve HIV-positive applicants.

Educational information from LifeInsuranceHIV.com, an independent brokerage. All coverage is subject to carrier underwriting and approval; eligibility, rates, and availability vary by carrier, state, and individual circumstances. Figures are estimates, not guarantees or offers of coverage.